Ioana Riaño

Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma

Ainhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz et al. · Journal of Hepatology · 2023 · 168 citations · Full text

Medicine, Oncology, Pathology +16

TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms

Aitor Esparza-Baquer, Ibone Labiano, Omar Sharif et al. · Gut · 2020 · 120 citations · Full text

Medicine, Immunology, Oncology +17

Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis

Ainhoa Lapitz, Ander Arbelaiz, Colm J. O’Rourke et al. · Cells · 2020 · 91 citations · Full text

Medicine, Oncology, Pathology +17

Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial

Hedwig M. A. D‘Agnolo, Wietske Kievit, R. Bart Takkenberg et al. · Journal of Hepatology · 2016 · 50 citations

Medicine, Internal Medicine, Pharmacotherapy +9

Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial)

Ioana Riaño, Leticia Martín, Marı́a Varela et al. · Cancers · 2020 · 31 citations · Full text

Medicine, Oncology, Pharmacotherapy +16